Development of inactivated cultural yellow fever vaccine

Development of inactivated cultural yellow fever vaccine

Introduction. The only currently available live vaccine against yellow fever (YF) based on chicken embryos infected with an attenuated 17D strain of the YF virus is one of the most effective vaccine preparations. However, the live vaccine is associated with “viscerotropic syndrome” (approximately 0....

Full description

Bibliographic Details
Main Authors:	A. P. Ivanov, T. D. Klebleeva, Y. V. Rogova, O. E. Ivanova
Format:	Article
Language:	English
Published:	Central Research Institute for Epidemiology 2020-09-01
Series:	Вопросы вирусологии
Subjects:	strain 17d of yellow fever virus cultural inactivated vaccine against yellow fever live vaccine against yellow fever vero cell culture purification of yellow fever virus immunogenicity balb/c mice
Online Access:	https://virusjour.crie.ru/jour/article/viewFile/408/270

Similar Items

The thermal stability of yellow fever vaccines
by: Ricardo Ishak, et al.
Published: (1990-09-01)

Travel pattern and profile of clients using online registration system and mobile accessibility for vaccination in a newly established yellow fever vaccination clinic at AIIMS Patna, India
by: Dhananjay Kumar, et al.
Published: (2017-01-01)

What Constitutes Protective Immunity Following Yellow Fever Vaccination?
by: Jolynne Mokaya, et al.
Published: (2021-06-01)

Ensuring the Safety of Yellow Fever Vaccination in Travelers—The Experience at a Large U.S. Academic Medical Center in Colorado
by: Mehdi Bandali, et al.
Published: (2020-07-01)

Evaluation of Two Adjuvant Formulations for an Inactivated Yellow Fever 17DD Vaccine Candidate in Mice
by: Ana Carolina dos Reis Albuquerque Cajaraville, et al.
Published: (2022-12-01)

Development and validation of RT-LAMP for detecting yellow fever virus in non-human primates samples from Brazil
by: Sabrina F. Cardoso, et al.
Published: (2024-09-01)

Yellow Fever Virus Vaccine Reduces T Cell Receptor Signaling and the Levels of Phosphatase PTPRE In Vivo
by: Jinhua Xiang, et al.
Published: (2020-06-01)

To vaccinate or let it be – current recommendations and the reality about yellow fever vaccination
by: Silja Bühler, et al.
Published: (2014-12-01)

Risk factors associated with in-hospital mortality during yellow fever outbreak in Brazil
by: Max McClure, et al.
Published: (2025-01-01)

Yellow fever vaccination: should India have more centres?
by: Vikas Bhatia, et al.
Published: (2015-01-01)

The early use of yellow fever virus strain 17D for vaccine production in Brazil - a review
by: Paulo Roberto Post, et al.
Published: (2001-08-01)

Experimental Yellow Fever in Squirrel Monkey: Characterization of Liver In Situ Immune Response
by: Milene S. Ferreira, et al.
Published: (2023-02-01)

Advanced Laboratory Methods for Detecting Yellow Fever Pathogen
by: E. I. Krivosheina, et al.
Published: (2021-07-01)

Enhancing Inactivated Yellow Fever 17D Vaccine-Induced Immune Responses in Balb/C Mice Using Alum/CpG
by: Yadan Zhang, et al.
Published: (2023-11-01)

Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines
by: Gerardo Montalvo Zurbia-Flores, et al.
Published: (2022-01-01)

Molecular analysis of yellow fever virus 17DD vaccine strain
by: Paulo R. Post, et al.
Published: (1991-06-01)

Vaccination against yellow fever in rheumatic diseases
by: B. S. Belov, et al.
Published: (2019-10-01)

YELLOW ALERT: Persistent Yellow Fever Virus Circulation among Non-Human Primates in Urban Areas of Minas Gerais State, Brazil (2021–2023)
by: Gabriela F. Garcia-Oliveira, et al.
Published: (2023-12-01)

A Yellow Fever Virus 17D Infection and Disease Mouse Model Used to Evaluate a Chimeric Binjari-Yellow Fever Virus Vaccine
by: Kexin Yan, et al.
Published: (2020-07-01)

Yellow fever virus: historical and current issues regarding recent epidemics and vaccination in Brazil
by: Ricardo Ishak, et al.
Published: (2020-04-01)

Prevalence and Diversity of Hepatitis Virus Markers among Patients with Acute Febrile Jaundice in Chad
by: Fissou Henry Yandai, et al.
Published: (2021-11-01)

A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old
Published: (2015-09-01)

Vaccines for yellow fever disease: A narrative review
by: Sumira Malik, et al.
Published: (2025-02-01)

Severe Multiorgan Failure Following Yellow Fever Vaccination
by: Cristina Domingo, et al.
Published: (2020-05-01)

Current Trends of Yellow Fever in Nigeria: Challenges and Prospects
by: Abdulkadir B., et al.
Published: (2019-12-01)

Molecular Characterization of Circulating Yellow Fever Viruses from Outbreak in Ghana, 2021–2022
by: Joseph Humphrey Kofi Bonney, et al.
Published: (2023-09-01)

Municipalities of higher vulnerability to Sylvatic Yellow Fever occurrence in the São Paulo State, Brazil
by: Eduardo Stramandinoli Moreno, et al.
Published: (2011-12-01)

Yellow fever vaccination: how much do travelers from Eastern India know?
by: Vikas Bhatia, et al.
Published: (2020-09-01)

Yellow Fever: a reason to be alert
by: Agustín Vega Vera
Published: (2004-04-01)

YELLOW FEVER PREVENTION STRATEGIES AWARENESS AMONG HIV-INFECTED PATIENTS IN SÃO PAULO, BRAZIL
by: Vivian Iida Avelino-Silva, et al.
Published: (2014-09-01)

The COVID-19 Impact on the Trends in Yellow Fever and Lassa Fever Infections in Nigeria
by: Nnennaya U. Opara, et al.
Published: (2022-11-01)

Chikungunya Fever in Traveler from Angola to Japan, 2016
by: Saho Takaya, et al.
Published: (2017-01-01)

Diversity of yellow fever mosquito vectors in the Atlantic Forest of Rio de Janeiro, Brazil
by: Jeronimo Alencar, et al.
Published: (2016-06-01)

Yellow fever
by: Aluízio Prata
Published: (2000-01-01)

Yellow fever
by: Prata Aluízio
Published: (2000-01-01)

The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences
by: Clarissa de Castro Ferreira, et al.
Published: (2018-01-01)

Yellow fever vaccine coverage and associated factors among under-five children in Kenya: Data from Kenyan Demographic and Health Survey 2022
by: Mohammed Seid Ali, et al.
Published: (2024-12-01)

Use of MAC-ELISA for evaluation of yellow fever vaccination Uso do MAC-ELISA para avaliação de vacinados contra febre amarela
by: Rita M. Ribeiro Nogueira, et al.
Published: (1992-10-01)

Experimental DNA-Launched Live-Attenuated Vaccines Against Yellow Fever
by: P. Pushko, et al.
Published: (2019-03-01)

Detection of Yellow Fever Virus in Sylvatic Mosquitoes during Disease Outbreaks of 2017–2018 in Minas Gerais State, Brazil
by: Guilherme Garcia Pinheiro, et al.
Published: (2019-05-01)